GREGORY BRANCHE: Open Payments
NPI 1598731135 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,503 in 80 payments from 14 companies in 2025. Trend: 2023 $1,608 · 2024 $2,365 · 2025 $2,503
Food & beverage: $2,493Education: $10
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 22 | $515 |
| Novartis Pharmaceuticals Corporation | 12 | $367 |
| ABBVIE INC. | 18 | $341 |
| Amgen Inc. | 6 | $315 |
| PFIZER INC. | 2 | $230 |
| GENZYME CORPORATION | 5 | $220 |
| Arcutis Biotherapeutics, Inc. | 2 | $143 |
| Lilly USA, LLC | 2 | $137 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $45 |
Products named: Bimzelx, OTEZLA, SKYRIZI, CIBINQO, DUPIXENT, COSENTYX, Zoryve, RINVOQ.
Industry payments across NY — which companies pay providers there.
